Exercise Electrocardiography in Women with Suspected Coronary Disease

  • Anthony P. Morise
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 235)


Exercise testing is a commonly used tool for the evaluation of atherosclerotic coronary artery disease. ST-segment depression has been a focus of interest as a marker of ischemia since at least 1928 (1). As early as 1950. Scherlis et al noted that, compared to men, normal women were more likely to have ST-segment abnormalities after exercise (2). Since then, most (if not all) studies have indicated a higher false-positive rate for ST-segment changes in women compared with men. From this body of literature emphasizing the higher false-positive rate comes the current perception that exercise electrocardiography is inherently less useful in women compared with men. The following review will examine recent developments in the accuracy of the exercise test in women, the role of hormones in the false-positive response, and the role of exercise testing in the evaluation of women with symptoms of suspected coronary disease.


Coronary Disease Estrogen Replacement Therapy Pretest Probability Referral Bias Pretest Score 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Feil H, Siegal ML. Electrocardiographic changes during attacks of angina pectoris. Am J Med Sci 1928;175:255–260.CrossRefGoogle Scholar
  2. 2.
    Scherlis L, Sandberg AA, Werner J, et al. Effects of single and double two-step exercise tests upon electrocardiogram of 200 normal persons. J Mt Sinai Hosp 1950;17:242–253.Google Scholar
  3. 3.
    Gianrossi R, Detrano R, Lehmann K, et al. Exercise-induced ST depression in the diagnosis of coronary artery disease: a meta-analysis. Circulation 1989;80:87–98.PubMedCrossRefGoogle Scholar
  4. 4.
    Kwok Y, Kim C, Grady D, et al. Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol 1999;83:660–666.PubMedCrossRefGoogle Scholar
  5. 5.
    Froelicher VF, Fearon WF, Ferguson CM, et al. Lessons learned from studies of the standard exercise ECG test. Chest 1999;116:1442–1451.PubMedCrossRefGoogle Scholar
  6. 6.
    Froelicher VF, Lehmann KG, Thmas R, et al. The electrocardiographic exercise test in a population with reduced work-up bias: diagnostic performance, computerized interpretation, and multivariable prediction. Ann Intern Med 1998;128:965–974.PubMedGoogle Scholar
  7. 7.
    Morise AP, Diamond GA. Comparison of the sensitivity and specificity of exercise electrocardiography in biased and unbiased populations of men and women. Am Heart J 1995;130:741–747.PubMedCrossRefGoogle Scholar
  8. 8.
    Morise AP, Dalai JN, Duval RD. Value of a simple measure of estrogen status for improving the diagnosis of coronary artery disease in women. Am J Med 1993;94:491–496.PubMedCrossRefGoogle Scholar
  9. 9.
    . Morise AP, Diamond GA, Detrano R, et al. Incremental value of exercise electrocardiography and thallium-201 testing I in men and women for the presence and extent of coronary artery disease. Am Heart J 1995;130:267-276. PubMedCrossRefGoogle Scholar
  10. 10.
    Jaffe MD. Effect of oestrogens on postexercise electrocardiogram. Br Heart J 1977;38: I299–1303.Google Scholar
  11. 11.
    Rosano GMC, Sarrel PM, Poole-Wilson PA. Beneficial effect of oestrogen on exercise-induced myocardial ischemia in women with coronary artery disease. Lancet 1993;342: 133–136.PubMedCrossRefGoogle Scholar
  12. 12.
    Rosano G, Rosano GMC, Sarrel PM, et al. Medroxyprogestcronc but not natural progesterone reverses the beneficial effect of estradiol 17heta upon exercise-induced myocardial ischemia. Circulation1996;94:I-18 (abstract).Google Scholar
  13. 13.
    Morise AP, Dalai JN, Duval RD. Frequency of oral estrogen replacement therapy in women with normal and abnormal exercise electrovardiograms and normal coronary arteries by angiogram. Am J Cardiol 1993;72:1197–1199.PubMedCrossRefGoogle Scholar
  14. 14.
    Morise AP, Belo R. The specificity of exercise electrocardiography in women grouped by estrogen status. Int J Cardiol 1997;60:55–65.PubMedCrossRefGoogle Scholar
  15. 15.
    Morise AP. Progestin therapy as a variable auxiliary to established predictors of positive exercise tests in women. JNoninvasive Cardiol 1997; 1:27–32.Google Scholar
  16. 16.
    Rovang KS, Arouni AJ, Mohiuddin SM, et al. Oral estrogen replacement therapy reduces the diagnostic accuracy of exercise stress tests in women. J Am Coll Cardiol 2000; 35:211 (abstract)Google Scholar
  17. 17.
    Clark PI, Glasser SP, Lyman GH, et al. Relation of results of exercise stress tests in young women to phases of the menstrual cycle. Am J Cardiol 1988;61:197–199.PubMedCrossRefGoogle Scholar
  18. 18.
    Marmor A, Zeira M, Zohar S. Effects of bilateral hystero-salpingo-oopherectomy on exercise-induced ST-segment abnormalities in young women. Am J Cordial 1993;71: 1118–1119.CrossRefGoogle Scholar
  19. 19.
    Gilligan DM, Badar DM, Panza JA, et al. Acute vascular effects of estrogen in postmenopausal women. Circulation 1994;90:786–91.PubMedCrossRefGoogle Scholar
  20. 20.
    Leiberman EH, Gerhard MD, Uehata A, et al. Estrogen improves endothelium-dependent flow-mediated vasodilation in postmenopausal women. Ann Intern Med 1994;121:93641.Google Scholar
  21. 21.
    Williams JK, Honore EK, Washburn SA, et al. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. J Am Coll Cordial 1994;24:1757–61.CrossRefGoogle Scholar
  22. 22.
    Sorensen KE, Dorup I, Hermann AP, et al. Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function. Circulation 1998;97:1234–8.PubMedCrossRefGoogle Scholar
  23. 23.
    Schlant RC, Blomqvist CG, Brandenburg RO, et al. Guidelines for exercise testing: a report of the joint American College of Cardiology/American Heart Association task force on assessment of cardiovascular procedures (subcommittee on exercise testing). Circulation I986;653A--667A.Google Scholar
  24. 24.
    Gibbons RJ, Balady GJ, Beasley JW, et al. ACC/AHA guidelines for exercise testing: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol 1997;30:260–315.PubMedCrossRefGoogle Scholar
  25. 25.
    Morise AP. Are the ACC/AHA guidelines for exercise testing for suspected coronary disease correct? Chest 2000 (in press).Google Scholar
  26. 26.
    . Morise AP, Haddad WI, Beckner D. Development and validation of a clinical score to estimate the probability of coronary artery disease in men and women presenting with suspected coronary disease. Am JMed 1997;102:350–6.Google Scholar
  27. 27.
    Morise AP, Haddad WJ. Validation of estrogen status as an independent predictor of coronary artery disease presence and extent in women. J Cardiovasc Risk 1997;3:507–11.CrossRefGoogle Scholar
  28. 28.
    Morise AP. Comparison of the Diamond-Forrester method and a new score to estimate the pretest probability of coronary disease before exercise testing. Am Heart J 1999;138; 740–5.PubMedCrossRefGoogle Scholar
  29. 29.
    Kim C, Kwok YS, Saha S, et al. Diagnosis of suspected coronary artery disease in women: a cost effectiveness analysis. Am Heart J 1999;137:1019–27.PubMedCrossRefGoogle Scholar
  30. 30.
    Shaw W, Hachamovitch R, Redberg RE Current evidence on diagnostic testing in women with suspected coronary artery disease. Cardiol in Review 2000;8:65–74.CrossRefGoogle Scholar
  31. 31.
    Alexander KP, Shaw LJ, Delong ER, et al. Value of exercise treadmill testing in women. JAm Coll Cardiol 1999;32:1657–64.CrossRefGoogle Scholar
  32. 32.
    Zellweger Mi, Lewin HC, Thompson TD, et al. Is the Duke treadmill score age and gender biased? Circulation 1999;100:I-505 (abstract).Google Scholar
  33. 33.
    Bairey Merz CN, Kelsey SF, Pepine CJ, et al. The Women’s lschemia Syndrome Evaluation (WISE) study: protocol, design, methodology and feasibility report. J Am Coll Cardiol 1999; 33:1453–61.CrossRefGoogle Scholar
  34. 34.
    Lewis JF, Lang L, McGorray S, et al. Dobutamine stress echocardiography in women with chest pain: pilot phase data from the National Heart, Lung and Blood Institute Women’s lschemia Syndrome Evaluation (WISE). JAm Coll Cardiol 1999;33:1462–8.CrossRefGoogle Scholar
  35. 35.
    Reis SE, Holubkov R, Lee JS, et al. Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease. Results from the pilot phase of the Women’s Ischemia Syndrome Evaluation (WISE) Study. JAm Coll Cardiol 1999;33:1469–75.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Anthony P. Morise
    • 1
  1. 1.West Virginia University School of MedicineMorgantownUSA

Personalised recommendations